Schwarz D A, Buhlmann J E, Kuhne M R, Lam T M, White H D, Green W R
Department of Microbiology, Dartmouth Medical School, Lebanon, New Hampshire 03756.
Cell Immunol. 1993 Aug;150(1):90-100. doi: 10.1006/cimm.1993.1181.
The ability of IFN-gamma to increase the expression of MHC class I gene products is likely to enhance cytolytic T lymphocyte recognition of viral pathogens and tumor cells. The murine lymphoma AKR SL3-cl.F AZR (SL3-cl.F) responds aberrantly to treatment with interferon-gamma such that H-2Dk surface expression is augmented, but H-2Kk expression remains at constitutive levels. Somatic cell fusions have been used to demonstrate that the lesion responsible for this phenotype is cis-dominant, implicating a primary lesion within the SL3-cl.F H-2Kk gene. In this communication, we have used PCR to analyze the nucleotide sequence in regions of the SL3-cl.F H-2Kk promoter known to contain interferon-responsive enhancer elements. Comparison of the SL3-cl.F H-2Kk sequences to known consensus elements revealed complete identity. In order to identify the lesion responsible for the SL3-cl.F phenotype, two H-2Kk genomic clones were independently isolated from SL3-cl.F. Each clone exists as a 10.5-kbp EcoRI fragment containing the entire structural gene. The site of transcription initiation is at the center of this fragment; therefore, all regulatory elements within 5 kbp of the transcript start site which could alter steady-state message levels are included. Interestingly, IFN-gamma-augmented expression of the H-2Kk gene was restored following DNA-mediated transfection of either of these clones into fibroblast cell lines and the parental cell line SL3-cl.F. Because isolation of these clones required passage of the DNA through a prokaryotic host, which alters the pattern of DNA methylation, there was the possibility that demethylation was responsible for the newly acquired IFN-gamma-responsive phenotype. Treatment of SL3-cl.F with 5-azacytidine, which inhibits de novo methylation, did not restore IFN-gamma-augmented expression, however, thus excluding H-2Kk specific methylation as a potential mechanism. Collectively, these data demonstrate that the alteration responsible for the phenotype observed in SL3-cl.F does not involve known transcriptional regulatory elements. Potential mechanisms which might account for the mutant phenotype are discussed.
γ干扰素增加MHC I类基因产物表达的能力可能会增强细胞毒性T淋巴细胞对病毒病原体和肿瘤细胞的识别。小鼠淋巴瘤AKR SL3-cl.F AZR(SL3-cl.F)对γ干扰素治疗反应异常,使得H-2Dk表面表达增加,但H-2Kk表达维持在组成水平。体细胞融合已被用于证明导致这种表型的病变是顺式显性的,这暗示了SL3-cl.F H-2Kk基因内的原发性病变。在本通讯中,我们使用聚合酶链反应(PCR)分析了SL3-cl.F H-2Kk启动子中已知含有干扰素反应增强子元件区域的核苷酸序列。将SL3-cl.F H-2Kk序列与已知的共有元件进行比较,发现完全相同。为了确定导致SL3-cl.F表型的病变,从SL3-cl.F中独立分离出两个H-2Kk基因组克隆。每个克隆以一个包含整个结构基因的10.5千碱基对(kbp)的EcoRI片段形式存在。转录起始位点位于该片段的中心;因此,转录起始位点5千碱基对范围内所有可能改变稳态信息水平的调控元件都被包括在内。有趣的是,将这些克隆中的任何一个通过DNA介导转染到成纤维细胞系和亲本细胞系SL3-cl.F后,H-2Kk基因的γ干扰素增强表达得以恢复。由于这些克隆的分离需要使DNA通过原核宿主,这会改变DNA甲基化模式,所以存在去甲基化导致新获得的γ干扰素反应表型的可能性。然而,用抑制从头甲基化的5-氮杂胞苷处理SL3-cl.F并没有恢复γ干扰素增强表达,因此排除了H-2Kk特异性甲基化作为一种潜在机制。总体而言,这些数据表明,导致SL3-cl.F中观察到的表型改变不涉及已知的转录调控元件。文中讨论了可能解释突变表型的潜在机制。